931 Search Results for

Newborns Affected by Neonatal Abstinence Syndrome Triple

September 5, 2016

A condition that causes newborns of substance-addicted mothers to experience withdrawal symptoms is on the rise. According to data from the Centers for Disease Control and Prevention, cases of neonatal abstinence syndrome (NAS) tripled between 1999 and 2013 in 23 states. In three states – West Virginia, Maine and Vermont – the condition now affects more than 30 infants per 1,000 births. Policymakers have proposed several solutions to address not only NAS but also opioid and heroin abuse, which are common contributors to the condition.

New Data Spark Debate on Cost and Value of Breakthrough Cholesterol Meds

August 30, 2016

A new analysis calls for drastic price reductions for PCSK9 inhibitors, breakthrough lipid-lowering medications. Data published in the Journal of the American Medical Association suggest that the treatments would need to be reduced to two-thirds their current price to meet analysts’ cost-effectiveness thresholds.

Hospitals Innovate on Pain Management and Opioid Abuse

August 23, 2016

Opioid-related deaths have tripled since 1999. Now, innovative hospitals are combatting opioid abuse by rethinking how they help patients manage surgical pain. In its recent webinar, the Collaborative for Effective Prescription Opioid Policies spotlighted several hospitals’ work toward better understanding – and minimizing – opioid abuse.

New Study: Aligning Rx Refill Dates Improves Patient Adherence

August 17, 2016

New research confirms that patients are more likely to follow their medication regimen if they receive all prescription drugs at the same time each month. Known as “synchronization,” the concept was the focus of a University of Pennsylvania study of Medicare Advantage patients.

Governors Take on Abuse and Access in Opioid Compact

August 4, 2016

State governors are ready to take action on the opioid abuse epidemic. The National Governors Association released “A Compact to Fight Opioid Addiction” on July 13 with the goals of reducing inappropriate opioid prescribing, improving awareness of risks and addiction, and clearing the way for addiction treatment and recovery.

Advocates Urge Congress to Finalize 21st Century Cures

August 2, 2016

Congress returns in September from a seven-week recess—and ready, many patients and advocates hope, to push the 21st Century Cures Act over the finish line. Senator Lamar Alexander (R-Tenn.) expects the Senate to resume work on the bill, which he says could be “the most important legislation Congress passes this year.” The bill passed the House of Representatives in July 2015 with bipartisan support.